Carmichael Hill & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Hold
0
231
2024
Q2
Hold
0
226
2024
Q1
Hold
0
226
2023
Q4
Hold
0
231
2023
Q3
Hold
0
218
2023
Q2
Hold
0
219

Other funds holding JNJ

Carmichael Hill & Associates's JNJ Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q3 2024, selling an estimated $76.5K and leaving 20,646 shares worth $3.35M. The position accounts for 1.19% of the portfolio, ranked #19.

Carmichael Hill & Associates first reported a position in JNJ in Q4 2017 and has held it in 28 quarters since. The position peaked at $4.2M in Q1 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Carmichael Hill & Associates held 20,646 shares of Johnson & Johnson worth $3.35M as of Q3 2024.
  • Carmichael Hill & Associates sold 480 Johnson & Johnson shares in Q3 2024, an estimated $76.5K.
  • Johnson & Johnson made up 1.19% of Carmichael Hill & Associates's portfolio in Q3 2024, its #19 holding.
  • Carmichael Hill & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Johnson & Johnson position peaked at $4.2M in Q1 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.